Meet Synlogic’s Aoife Brennan, Fireside Chat Speaker at #BIOCEO19
BIOtech Now Theresa Brady Dr. Aoife Brennan has always faced challenges head-on. A trained endocrinologist, she could have remained in her native […]
Category: News
Latest Measles Outbreak is a Crash Course on the Importance of Immunization
BIOtech Now Jim Greenwood It’s hard to miss the news coming from the Pacific Northwest. Every major media outlet is covering the […]
Here’s What You Need to Know as Capitol Hill Talks Prescription Drug Costs
BIOtech Now Andrew Segerman Drug prices will be in the spotlight this week as committees in both the House and Senate are […]
A Helpful Spotlight on the Need for More Health Care Transparency
BIOtech Now Brian Newell This week, the Trump administration addressed a problem confronting a growing number of Americans: surprise medical bills. As […]
Greenwood Shines Spotlight on Insurance Industry Rip-off
BIOtech Now Andrew Segerman Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a shocking Wall Street […]
Using Biotechnology to Tackle Deadly Mosquito-Borne Illnesses
BIOtech Now Josh Falzone Every year, nearly a million deaths are attributed to mosquito-borne illnesses and 500 million people are infected with […]
Despite Administration’s “Sky-High Rhetoric,” Importing Foreign Price Controls Will Harm Innovation and Patient Access
BIOtech Now Andrew Segerman In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines […]
The Right Way to Address Prescription Drug Costs
BIOtech Now Andrew Segerman Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City Capital’s David Beier […]
BIO Illustrates the Success of the Orphan Drug Act
BIOtech Now Andrew Segerman The numbers might surprise you. Approximately 7,000 rare diseases are known to exist, and approximately 30 new ones […]
The Administration’s Orwellian Defense of Importing Foreign Price Controls
BIOtech Now Brian Newell The Trump administration is out with a new blog post defending its plan to adopt foreign price controls […]
Greenwood Talks Innovation, Drug Pricing, and the Midterm Elections on ForbesBooks Radio
BIOtech Now Andrew Segerman During the Forbes Healthcare Summit, BIO CEO Jim Greenwood joined Gregg Stebben, host of ForbesBooks Radio, for a […]
Greenwood: Think the Drug-Pricing debate addresses Patient Costs? Think again.
BIOtech Now Andrew Segerman Writing for The Hill, BIO President and CEO Jim Greenwood tackled the drug pricing debate in Washington and […]
Claims of Gene-Edited Twins Met with Criticism and Concern
BIOtech Now Andrew Segerman As the Second International Summit on Human Genome Editing wraps in Hong Kong this week, breaking news dominated much […]
Alzheimer’s Awareness Month: Hope on the Horizon
BIOtech Now Andrew Segerman Did you know that more than 5 million Americans are currently living with Alzheimer’s disease? If that number […]
Another Year, Another Misleading Insurance Company Report
BIOtech Now Brian Newell Once again, Blue Cross Blue Shield is out with a report attempting to stoke fear and confusion about […]
Survey Says: Solutions to Combat Against Antimicrobial Resistance Needed
BIOtech Now Andrew Segerman Writing for The Hill, Dr. Cynthia Sears, president of the Infectious Diseases Society of America (IDSA), discussed the […]
Patient and Health Advocacy Summit: Ensuring Patient Access and Affordability
BIOtech Now Andrew Segerman In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines […]
BIO Patient & Health Advocacy Summit Concludes Today
BIOtech Now Theresa Brady Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to […]
Patient Advocates Sounding the Alarm Over Fail First
BIOtech Now Andrew Segerman The Centers for Medicare & Medicaid Services (CMS) has reversed a long-standing policy allowing Medicare Advantage plans to […]
Making SMA Newborn Screening a Reality: Collaborating with the Patient Advocacy Community
BIOtech Now BIOtechNOW Editor Each year, roughly 12,500 newborns in the U.S., or one out of every 300 infants, are diagnosed with […]